Found 176 results
Filters: Keyword is Female  [Clear All Filters]
2017
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung H-P, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K et al..  2017.  Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.. N Engl J Med. 376(3):221-234.
Murthy SB, Merkler AE, Omran SSalehi, Gialdini G, Gusdon A, Hartley B, Roh D, Mangat HS, Iadecola C, Navi BB et al..  2017.  Outcomes after intracerebral hemorrhage from arteriovenous malformations.. Neurology. 88(20):1882-1888.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, Connaughty C, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery.. PLoS One. 12(10):e0185926.
Murthy SB, Awad I, Harnof S, Aldrich F, Harrigan M, Jallo J, Caron J-L, Huang J, Camarata P, Lara LRivera et al..  2017.  Permanent CSF shunting after intraventricular hemorrhage in the CLEAR III trial.. Neurology. 89(4):355-362.
Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.  2017.  Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.. AJR Am J Roentgenol. 209(4):889-894.
Merkler AE, Ch'ang J, Parker WE, Murthy SB, Kamel H.  2017.  The Rate of Complications after Ventriculoperitoneal Shunt Surgery.. World Neurosurg. 98:654-658.
Parikh NS, Burch JE, Kamel H, DeAngelis LM, Navi BB.  2017.  Recurrent Thromboembolic Events after Ischemic Stroke in Patients with Primary Brain Tumors.. J Stroke Cerebrovasc Dis. 26(10):2396-2403.
Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al..  2017.  Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.
Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, Osorio RS, Pupi A, Vallabhajosula S, Isaacson RS et al..  2017.  Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.. Neurology. 89(13):1382-1390.
Mercuri MA, White H, Oliveira C.  2017.  Vision Loss and Symmetric Basal Ganglia Lesions in Leber Hereditary Optic Neuropathy.. J Neuroophthalmol. 37(4):411-413.
2016
Parikh NS, Navi BB, Kumar S, Kamel H.  2016.  Association between Liver Disease and Intracranial Hemorrhage.. J Stroke Cerebrovasc Dis. 25(3):543-8.
Parikh NS, Khazanova D, Moya A, Kaunzner UW, Allen BB, Navi BB.  2016.  Clinical Reasoning: An unusual case of blurry vision in a young woman after ovarian induction.. Neurology. 87(5):e49-53.
Ebben MR, Krieger AC.  2016.  Diagnostic accuracy of a mathematical model to predict apnea-hypopnea index using nighttime pulse oximetry.. J Biomed Opt. 21(3):35006.
Nguyen TD, Deh K, Monohan E, Pandya S, Spincemaille P, Raj A, Wang Y, Gauthier SA.  2016.  Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST-T2) at 3T.. Magn Reson Med. 76(2):456-65.
Chiang GC, Pinto S, Comunale JP, Gauthier SA.  2016.  Gadolinium-Enhancing Lesions Lead to Decreases in White Matter Tract Fractional Anisotropy in Multiple Sclerosis.. J Neuroimaging. 26(3):289-95.
Merkler AE, Parikh NS, Chaudhry S, Chait A, Allen NC, Navi BB, Kamel H.  2016.  Hospital revisit rate after a diagnosis of conversion disorder.. J Neurol Neurosurg Psychiatry. 87(4):363-6.
Zhang Y, Gauthier SA, Gupta A, Comunale J, Chiang GChia-Yi, Zhou D, Chen W, Giambrone AE, Zhu W, Wang Y.  2016.  Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM).. J Magn Reson Imaging. 44(2):426-32.
Dayan M, Monohan E, Pandya S, Kuceyeski A, Nguyen TD, Raj A, Gauthier SA.  2016.  Profilometry: A new statistical framework for the characterization of white matter pathways, with application to multiple sclerosis.. Hum Brain Mapp. 37(3):989-1004.
Zhang Y, Gauthier SA, Gupta A, Chen W, Comunale J, Chiang GC-Y, Zhou D, Askin G, Zhu W, Pitt D et al..  2016.  Quantitative Susceptibility Mapping and R2* Measured Changes during White Matter Lesion Development in Multiple Sclerosis: Myelin Breakdown, Myelin Debris Degradation and Removal, and Iron Accumulation.. AJNR Am J Neuroradiol. 37(9):1629-35.
Murthy SB, Urday S, Beslow LA, Dawson J, Lees K, W Kimberly T, Iadecola C, Kamel H, Hanley DF, Sheth KN et al..  2016.  Rate of perihaematomal oedema expansion is associated with poor clinical outcomes in intracerebral haemorrhage.. J Neurol Neurosurg Psychiatry. 87(11):1169-1173.
Navi BB, Parikh NS, Lerario MP, Merkler AE, Lappin RI, Fahimi J, Iadecola C, Kamel H.  2016.  Risk of Intracerebral Hemorrhage after Emergency Department Discharges for Hypertension.. J Stroke Cerebrovasc Dis. 25(7):1683-1687.
Lerario MP, Merkler AE, Gialdini G, Parikh NS, Navi BB, Kamel H.  2016.  Risk of Stroke After the International Classification of Diseases-Ninth Revision Discharge Code Diagnosis of Hypertensive Encephalopathy.. Stroke. 47(2):372-5.
Parikh NS, Cool J, Karas MG, Boehme AK, Kamel H.  2016.  Stroke Risk and Mortality in Patients With Ventricular Assist Devices.. Stroke. 47(11):2702-2706.
Baradaran H, Omran S, J Chazen L.  2016.  Teaching NeuroImages: Acute crossed cerebellar diaschisis.. Neurology. 86(14):e154-e155.